Oracle Unveils Oracle Health Sciences Omics Data Bank as Part of Oracle Health Sciences Translational Research Center

REDWOOD SHORES, CA, Jan 23, 2012 -- Oracle ORCL +0.53%

News Facts
-- Oracle Health Sciences today announced availability of Oracle Health
Sciences Omics Data Bank, a molecular data model, which is part of
Oracle Health Sciences Translational Research Center. The new data
model provides integration and analysis of cross-platform omics data
to support translational research.
-- Oracle Health Sciences Translational Research Center enables
pharmaceutical and biotech companies, contract research organizations,
as well as academic research organizations to normalize, aggregate,
and analyze data from numerous internal and external sources,
including clinical systems, lab systems, next-generation sequencing
platforms, and biobanks, to identify new predictive biomarkers, best
practices for diagnosis and treatment, and more effective personalized
therapies.
-- Oracle Health Sciences Omics Data Bank enables turnkey integration and
analysis of multiple types of molecular data, including whole genome
sequencing and gene expression data irrespective of the platform used.
The omics data model provides researchers with unprecedented power and
agility in analyzing large molecular data sets from internal and
external sources.
-- The solution also includes out-of-the-box adapters for loading
customer generated molecular profiling data, as well as public domain
data from sources such as Ensembl, The Cancer Genome Atlas and Pathway
Commons, to further speed time to value.
-- Oracle Health Sciences Translational Research Center scales to support
large, global studies incorporating thousands of whole genome
sequences while ensuring appropriate levels of security and access
control.
-- Oracle Health Sciences Translational Research Center runs on Oracle
Exadata Database Machine delivering the extreme performance required
for querying vast data sets.

Supporting Quotes

-- "The release of Oracle Health Sciences Omics Data Bank for Oracle
Health Sciences Translational Research Center demonstrates Oracle's
continued commitment to making personalized medicine a reality," said
Neil de Crescenzo, senior vice president and general manager, Oracle
Health Sciences. "Molecular data is a critical component of any
translational medicine initiative, and Oracle Health Sciences
Translational Research Center now has the power to help researchers
address the big data challenges associated with bioinformatics."
-- "With the rapidly dropping cost of whole genome sequencing, the
challenge for personalized medicine is moving from generation of the
data to analysis," said Dr. Brian Druker, M.D., director, Oregon
Health & Science University Knight Cancer Institute. "Oracle
Health Sciences Translational Research Center represents an important
step forward."
-- "The Inova Translational Medicine Institute (ITMI) is in the midst of
one of the largest genome sequencing projects ever," said Dr. John
Niederhuber, Chief Executive Officer, Inova Translational Medicine
Institute and former Director of the National Cancer Institute. "Our
goal is to unlock new insights in pre-term delivery. We hope to
identify genomic alternations that identify high risk patients early
in their pregnancy, so that they may take advantage of therapies
designed to delay pre-term delivery. Working with the outstanding NICU
physicians and nurses at Inova Fairfax Hospital, ITMI anticipates that
our research will enhance our understanding of the mechanisms that
lead to pre-term delivery. Oracle is uniquely positioned to support
the complete integration of our clinical data with data from the 1,500
whole genomes sequenced as a part of the project, providing us with
the platform required to perform genomic analyses, leading to improved
patient care through personalized genomic medicine."

 

Supporting Resources

-- Oracle in Health Sciences
-- Follow Oracle Health Sciences on Twitter
-- Join the Oracle Health Sciences Community on Facebook
-- Video: Oracle Health Sciences Translational Research Center
-- Oracle Health Sciences on YouTube
-- Oracle Health Sciences Translational Research Center
-- Press Release: Oracle Introduces Oracle Health Sciences Translational
Research Center to Support Industry Transition to Personalized
Medicine

About Oracle Oracle engineers hardware and software to work together in the cloud and in your data center. For more information about Oracle ORCL +0.53% , visit www.oracle.com .

Trademark Oracle is a registered trademark of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

Contact Info

Greg Lunsford
Oracle
+1.650.506.6523
Email Contact

Mary Tobin
O'Keeffe & Company
+1.503.658.7396
Email Contact

SOURCE: Oracle Corporation

Suggested Articles

Robertson, M.D., who led global development teams within Shire’s neuroscience division, is now Yumanity Therapeutics’ chief medical officer.

Novo Nordisk and Dicerna are teaming up on liver-related diseases, including nonalcoholic steatohepatitis (NASH), to the tune of $225 million.

After announcing it was slashing scores of jobs, Alkermes is now willing to put down nearly $1 billion to buy out CNS biotech Rodin Therapeutics.